PubMed Health⌕ Search

PubMed · 11866942

[Cushing syndrome--a pathologic analysis based on 216 resected specimens].

Abstract

OBJECTIVE: To study the morphological features of adrenal cortex in Cushing's syndrome and the correlation of morphological changes with clinical manifestations. METHODS: 216 cases of Cushing's syndrome were collected. Among these there were 160 cases of adrenal hyperplasia, 50 cases of adenoma and 6 cases of adenocarcinoma of adrenal cortex. The morphometric method was used to measure the thickness of adrenal cortex microscopically. The weight of the resected specimens were carefully recorded and correlated with clinical laboratory findings and clinical manifestations. RESULTS: In adrenal cortex hyperplasia, the thickness and weight of the adrenal cortex increased gradually in the order of mild, moderate and severe hyperplasia. The hyperplasia and hypertrophy of the compact cell are very common in these specimens. The frequency of compact cell predominant cases was also increased in severe hyperplasia. The weight and size of the tumor differed significantly between adenoma and adenocarcinoma of the adrenal cortex. CONCLUSION: In Cushing's syndrome, adrenal cortex hyperplasia is the most common. The grade of hyperplasia was well correlated with clinical laboratory findings. Increase of frequency of compact cell predominance is important morphological feature of hyperplasia of adrenal cortex. Adenoma should be considered when atrophy of adjacent cortex is present. The tumor size and weight as well as mitosis are important parameters in differential diagnosis between adenoma and adenocarcinoma of the adrenal cortex, but the infiltration of capsule and blood vessels and/or metastasis still remain the gold criteria for diagnosis of adrenal adenocarcinoma.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Chen, T Liu. 2000. [Cushing syndrome--a pathologic analysis based on 216 resected specimens].. https://pubmed.ncbi.nlm.nih.gov/11866942/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Difficulty in the diagnosis of Cushing disease.

BACKGROUND: A 48-year-old woman presented to our clinic 1 year after hypertension was discovered on a routine screening visit. During the previous year, she had noticed weight gain in the face and abdomen, easy bruising, oligomenorrhea and facial and periareolar hair growth. On presentation, she reported no weakness, fracture, back pain, depression, irritability, problem with cognition or memory, increased appetite, hot flashes or altered sleep. Previous medication history included 2.5 mg lisinopril daily and 25.0 mg hydrochlorothiazide daily for 12 months. INVESTIGATIONS: Measurement of urine glucocorticoid excretion, evening plasma and salivary cortisol levels, and basal and corticotropin-releasing-hormone-stimulated adrenocorticotropic hormone and cortisol levels. An overnight 8 mg dexamethasone suppression test, pituitary MRI, inferior-petrosal-sinus sampling, cavernous sinus and jugular venous sampling were performed. DIAGNOSIS: Cushing disease. MANAGEMENT: The patient underwent trans-sphenoidal resection, assessment of remission and subsequent treatment with hydrocortisone.

17-Hydroxycorticosteroids↗

Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.

OBJECTIVE: To further analyse the significance and mutual relationship of thyroid function-linked alterations in cortisol metabolism that have been separately and variously reported. PATIENTS AND MEASUREMENTS: Twenty-four-hour urine samples from 21 patients with hyperthyroidism (Graves' disease), 16 patients with hypothyroidism (Hashimoto's thyroiditis), 21 healthy age- and sex-matched controls for hyperthyroidism, and 16 healthy age- and sex-matched controls for hypothyroidism were evaluated for 6beta-hydroxycortisol (6beta-OHF), tetrahydrocortisol (THF), tetrahydrocortisone (THE), allo-tetrahydrocortisol (allo-THF), urinary free cortisol (UFF), urinary free cortisone (UFE) and 17-hydroxycorticosteroid (17-OHCS). RESULTS: Urinary 17-OHCS, THE and allo-THF levels increased considerably in hyperthyroid patients compared to the controls, while UFF and THF showed no difference between the two groups. Urinary 6beta-OHF was significantly lower in the hyperthyroid patients than in the controls. Both the urinary allo-THF + THF/THE and the UFF/UFE ratios were significantly lower in the hyperthyroid patients than in the controls, whereas only the former was significantly higher in the hypothyroid patients than in the controls. The urinary allo-THF/THF ratio was significantly higher in the hyperthyroid patients and significantly lower in the hypothyroid patients than in the controls. In an analysis of pooled subjects including all groups (n = 64), free T4 levels correlated negatively (P < 0.0001) with the urinary allo-THF + THF/THE ratio but not with the UFF/UFE ratio. The serum levels of free T4 correlated positively (P < 0.0001) with the urinary allo-THF/THF ratio. CONCLUSION: The thyroid hormones seem to affect the total 11beta-HSD activity (allo-THF + THF/THE) more strongly than the renal 11beta-HSD2 activity (UFF/UFE). 5alpha-reductase activity (allo-THF/THF) is also enhanced in hyperthyroidism, while the reduction of urinary 6beta-OHF in hyperthyroidism might be a secondary effect of the altered activity of the total 11beta-HSD and 5alpha-reductase.

17-Hydroxycorticosteroids↗